Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy

NCT03972917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2023-01-18

No results posted yet for this study

Summary

A prospective observational study on italian women undergoing ulipristal acetate (uPa) therapy for symptomatic myomas and its impact on symptomatology and moreover on myomas architecture. We also evaluate changes in the endometrial pattern of selected women.

Conditions

  • Myoma
  • Uterine Bleeding, Dysfunctional
  • Uterine Bleeding Heavy
  • Dysmenorrhea
  • Endometrium Hyperplasia

Interventions

DIAGNOSTIC_TEST

Transvaginal ultrasonographic examination

Evaluation of endometrial thickness; myoma size and volume

Sponsors & Collaborators

  • University of Campania Luigi Vanvitelli

    lead OTHER

Principal Investigators

  • Gaetano Riemma, MD · University of Campania Luigi Vanvitelli

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-07-10
Completion
2021-09-21

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03972917 on ClinicalTrials.gov